Horan Capital Advisors, Llc. Amgen Inc Transaction History

Horan Capital Advisors, Llc.

$279 Million
Q1 2024

A detailed history of Horan Capital Advisors, Llc. transactions in Amgen Inc stock. As of the latest transaction made, Horan Capital Advisors, Llc. holds 13,235 shares of AMGN stock, worth $4.14 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares

13,235

Previous 13,334 0.74%

Holding current value

$4.14 Million

Previous $3.84 Million 2.03%

% of portfolio

1.35%

Previous 1.42%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$268.87 - $324.56 $26,618 - $32,131	-99 Reduced 0.74%	13,235 $3.76 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $154,442 - $174,229	-604 Reduced 4.33%	13,334 $3.84 Million
Q3 2023 Nov 01, 2023	SELL	$218.65 - $271.46 $55,755 - $69,222	-255 Reduced 1.8%	13,938 $3.75 Million
Q2 2023 Aug 01, 2023	BUY	$214.27 - $253.37 $27,640 - $32,684	129 Added 0.92%	14,193 $3.15 Million
Q1 2023 May 01, 2023	BUY	$225.79 - $275.2 $3.18 Million - $3.87 Million	14,064 New	14,064 $3.4 Million

Q4 2020 Feb 02, 2021	SELL	$216.38 - $257.67 $121,605 - $144,810	-562 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$234.65 - $260.95 $131,873 - $146,653	562 New	562 $143,000
Q1 2020 Apr 29, 2020	SELL	$182.24 - $241.7 $104,241 - $138,252	-572 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$189.21 - $243.2 $378 - $486	-2 Reduced 0.35%	572 $138,000
Q3 2019 Oct 22, 2019	BUY	$174.11 - $208.62 $99,939 - $119,747	574 New	574 $111,000
Q2 2019 Jul 26, 2019	SELL	$166.7 - $195.41 $91,518 - $107,280	-549 Closed	0 $0
Q1 2019 Apr 22, 2019	BUY	$180.87 - $203.88 $99,297 - $111,930	549 New	549 $104,000
Q4 2017 Feb 06, 2018	SELL	$168.79 - $188.59 $136,213 - $152,192	-807 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $135,003 - $154,137	807	807 $150,000

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Horan Capital Advisors, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Horan Capital Advisors, Llc. with notifications on news.

Account

Horan Capital Advisors, Llc. Amgen Inc Transaction History